How many 8-K filings has Genedx Holdings Corp. filed?

Genedx Holdings Corp. (WGSWW) has 10 8-K (Current Event Report) filings on record, spanning Jan 2024 to Sep 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Genedx Holdings Corp. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Genedx Holdings Corp. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Genedx Holdings Corp. (WGSWW) — 8-K Filings

All 8-K filings from Genedx Holdings Corp.. Browse 10 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (10)

GeneDx Holdings Corp. Reports Director Departure, Officer Changes — Sep 18, 2025 Risk: medium
GeneDx Holdings Corp. announced on September 17, 2025, the departure of Director Dr. Jonathan S. Roth. The company also reported on the election of new director
GeneDx Holdings Corp. Files 8-K on Security Holder Votes & Financials — Jun 18, 2025 Risk: low
On June 18, 2025, GeneDx Holdings Corp. filed an 8-K report detailing a submission of matters to a vote of security holders and financial statements. The compan
GeneDx Holdings Corp. Files 8-K: Material Agreement & Equity Sales — Apr 16, 2025 Risk: medium
On April 15, 2025, GeneDx Holdings Corp. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and
GeneDx Holdings Corp. Files 8-K on Financials — Feb 18, 2025 Risk: low
GeneDx Holdings Corp. filed an 8-K on February 18, 2025, reporting on its results of operations and financial condition. The filing also includes financial stat
GeneDx Holdings Corp. Files 8-K on Financials — Jan 13, 2025 Risk: low
GeneDx Holdings Corp. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD d
GeneDx Holdings Corp. Reports Board Changes and Compensation Updates — Jan 2, 2025 Risk: medium
GeneDx Holdings Corp. announced on January 2, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure
GeneDx Holdings Corp. Files 8-K on Shareholder Votes and Financials — Jun 24, 2024 Risk: low
GeneDx Holdings Corp. filed an 8-K on June 24, 2024, reporting on matters submitted to a vote of security holders and financial statements as of June 20, 2024.
GeneDx Holdings Corp. Files Material Definitive Agreement — Apr 29, 2024 Risk: medium
On April 29, 2024, GeneDx Holdings Corp. filed an 8-K report detailing a material definitive agreement. The company, formerly known as Sema4 Holdings Corp., is
GeneDx Holdings Corp. Files 8-K on Financial Condition — Feb 20, 2024 Risk: medium
GeneDx Holdings Corp. filed an 8-K on February 20, 2024, reporting on its results of operations and financial condition. The filing indicates the company's curr
GeneDx Updates Corporate Address & Contact Info in Routine 8-K — Jan 8, 2024
GeneDx Holdings Corp. filed an 8-K on January 8, 2024, to update its corporate information, specifically its principal executive offices to 333 Ludlow Street, N

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX